Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651104.RA-mtYLcS0D7xn_rNU3CdABmUBqvLZe9fxslF504dnfrg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651104.RA-mtYLcS0D7xn_rNU3CdABmUBqvLZe9fxslF504dnfrg130_assertion type Assertion NP651104.RA-mtYLcS0D7xn_rNU3CdABmUBqvLZe9fxslF504dnfrg130_head.
- NP651104.RA-mtYLcS0D7xn_rNU3CdABmUBqvLZe9fxslF504dnfrg130_assertion description "[Using HIV-infected women with CD4 >750 cells/microL as the reference category, the odds ratios for reporting zoster since the prior visit were: 1.43 (95% CI 0.86-2.37) for CD4 500-749 cells/microL, 2.07 (95% CI 1.27-3.38) for CD4 350-499 cells/microL, 2.72 (95% CI 1.66-4.46) for CD4 200-349 cells/microL, and 3.16 (95% CI 1.92-5.18) for CD4 <200 cells/microL, compared with 0.11 (95% CI 0.046-0.26) for HIV-uninfected women.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651104.RA-mtYLcS0D7xn_rNU3CdABmUBqvLZe9fxslF504dnfrg130_provenance.
- NP651104.RA-mtYLcS0D7xn_rNU3CdABmUBqvLZe9fxslF504dnfrg130_assertion evidence source_evidence_literature NP651104.RA-mtYLcS0D7xn_rNU3CdABmUBqvLZe9fxslF504dnfrg130_provenance.
- NP651104.RA-mtYLcS0D7xn_rNU3CdABmUBqvLZe9fxslF504dnfrg130_assertion SIO_000772 15577417 NP651104.RA-mtYLcS0D7xn_rNU3CdABmUBqvLZe9fxslF504dnfrg130_provenance.
- NP651104.RA-mtYLcS0D7xn_rNU3CdABmUBqvLZe9fxslF504dnfrg130_assertion wasDerivedFrom befree-20140225 NP651104.RA-mtYLcS0D7xn_rNU3CdABmUBqvLZe9fxslF504dnfrg130_provenance.
- NP651104.RA-mtYLcS0D7xn_rNU3CdABmUBqvLZe9fxslF504dnfrg130_assertion wasGeneratedBy ECO_0000203 NP651104.RA-mtYLcS0D7xn_rNU3CdABmUBqvLZe9fxslF504dnfrg130_provenance.